Victoza for weight loss: what liraglutide actually does

What did @rhondagsigler actually say?

Rhonda shared a weight loss update while on liraglutide (Victoza), noting she'd broken through a stall after dealing with constipation, stress, and poor food choices. She plans to increase her dose from 2.4 mg to "the 3.0 max" and says her doctor lets her decide when to move up. She also flagged worsening stomach bruising at higher doses and asked followers about switching injection sites for better efficacy.

To her credit, she connects the lifestyle basics, protein intake, hydration, bowel regularity, sleep routines, and mental health, to her overall progress. She's not selling anything or making outrageous claims. But a few things she said deserve a closer look, because they're either medically off or could lead viewers in the wrong direction.

Does the science back this up?

The stress-weight connection is real, the injection site efficacy question is more complicated than she suggests, and the dose numbers she's citing don't quite line up with how Victoza actually works.

On stress: cortisol does promote fat storage, particularly visceral fat, and disrupts hunger-regulating hormones like leptin and ghrelin. A 2022 review by Xenaki et al. in Hormones confirmed that chronic psychological stress is associated with weight gain and poorer dietary choices, especially in women. She's right on that one.

On injection sites: a 2021 meta-analysis by Hofman et al. in Diabetes Care found that absorption of subcutaneous GLP-1 medications can vary modestly by site, with the abdomen generally showing the most consistent absorption. Her claim that the thigh is "statistically the least effective spot" has some basis, but the clinical difference is typically small and varies by individual.

On dosing: liraglutide for weight management is sold as Saxenda, not Victoza. Victoza tops out at 1.8 mg for type 2 diabetes. Saxenda goes up to 3.0 mg. Mixing up these two products matters, because they have different approved indications and titration schedules.

What did they get wrong (or right)?

The dose numbers are the clearest problem here. She says she's on "2.4" and going up to "3.0 max." Those are Saxenda doses, not Victoza doses. Victoza's maximum approved dose is 1.8 mg. If she's actually on 2.4 mg of liraglutide, she is on Saxenda, not Victoza, regardless of what she calls it. That's not a nitpick. The two products have different labeling, different approved uses, and different titration protocols. Using the wrong name in a video with 11,800 views could genuinely confuse people about what medication they're on or what doses are appropriate.

The self-directed dosing setup she describes, where her doctor lets her choose when to increase, is not standard practice. Saxenda has a defined titration schedule (0.6 mg weekly increases) specifically to reduce GI side effects. Patient-controlled titration outside that structure isn't supported by the prescribing guidelines and could increase adverse event risk.

What she got right: her instinct to address constipation before increasing dose is actually sound. GI side effects worsen with faster titration. The bruising concern is legitimate and worth raising with her prescriber, not crowdsourcing on TikTok.

What should you actually know?

If you're on liraglutide for weight loss, you are almost certainly on Saxenda, not Victoza. They contain the same molecule but are different products with different approved doses. Victoza is approved for type 2 diabetes at up to 1.8 mg. Saxenda is approved for chronic weight management at up to 3.0 mg. Calling one the other creates real confusion about dosing expectations.

On bruising: injection site bruising with liraglutide tends to worsen if you're reusing the same small area repeatedly, injecting too quickly, or not letting alcohol dry before injecting. It is worth bringing up with your provider, not because it signals danger, but because technique adjustments usually help. Rotating sites within the recommended zones, abdomen, thigh, upper arm, is the standard recommendation.

On patient-controlled titration: some clinicians do offer flexibility, but that flexibility should happen within a medically supervised framework, not based on how you're feeling about your bowel movements this week. If you're not sure whether your dose increase schedule is clinically appropriate, ask your prescriber directly.